Progyny Inc

Company Profile

Progyny Inc had its IPO on 2019-10-25 under the ticker symbol PGNY.

The company operates in the Healthcare sector and Health Information Services industry. Progyny Inc has a staff strength of 393 employees.

Stock update

Shares of Progyny Inc opened at $36.98 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $36.58 - $37.8, and closed at $36.62.

This is a -1.21% slip from the previous day's closing price.

A total volume of 524,668 shares were traded at the close of the day’s session.

In the last one week, shares of Progyny Inc have slipped by -2.01%.

Progyny Inc's Key Ratios

Progyny Inc has a market cap of $3.57 billion, indicating a price to book ratio of 8.363 and a price to sales ratio of 4.0555.

In the last 12-months Progyny Inc’s revenue was $957.46 million with a gross profit of $167.33 million and an EBITDA of $46.68 million. The EBITDA ratio measures Progyny Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Progyny Inc’s operating margin was 4.67% while its return on assets stood at 4.89% with a return of equity of 12.63%.

In Q2, Progyny Inc’s quarterly earnings growth was a positive 66.7% while revenue growth was a positive 43.3%.

Progyny Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

77.8542

PEG

Its diluted EPS in the last 12-months stands at $0.48 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Progyny Inc’s profitability.

Progyny Inc stock is trading at a EV to sales ratio of 3.9513 and a EV to EBITDA ratio of 129.7716. Its price to sales ratio in the trailing 12-months stood at 4.0555.

Progyny Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$681.54 million

Total Liabilities

$193.90 million

Operating Cash Flow

$-58923000.00

Capital Expenditure

$759000

Dividend Payout Ratio

0%

Progyny Inc ended 2024 with $681.54 million in total assets and $0 in total liabilities. Its intangible assets were valued at $681.54 million while shareholder equity stood at $469.50 million.

Progyny Inc ended 2024 with $0 in deferred long-term liabilities, $193.90 million in other current liabilities, 9000.00 in common stock, $60.60 million in retained earnings and $11.88 million in goodwill. Its cash balance stood at $170.57 million and cash and short-term investments were $282.50 million. The company’s total short-term debt was $0 while long-term debt stood at $0.

Progyny Inc’s total current assets stands at $561.13 million while long-term investments were $0 and short-term investments were $111.93 million. Its net receivables were $264.96 million compared to accounts payable of $130.16 million and inventory worth $0.

In 2024, Progyny Inc's operating cash flow was $-58923000.00 while its capital expenditure stood at $759000.

Comparatively, Progyny Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$36.62

52-Week High

$45.98

52-Week Low

$28.03

Analyst Target Price

$46

Progyny Inc stock is currently trading at $36.62 per share. It touched a 52-week high of $45.98 and a 52-week low of $45.98. Analysts tracking the stock have a 12-month average target price of $46.

Its 50-day moving average was $38.66 and 200-day moving average was $35.34 The short ratio stood at 8.09 indicating a short percent outstanding of 0%.

Around 114.9% of the company’s stock are held by insiders while 10093% are held by institutions.